DA Davidson analyst Gil Luria raised the firm’s price target on UiPath (PATH) to $14 from $11 and keeps a Neutral rating on the shares. The company’s Q1 results showed “healthy” outperformance, improved business tone, and early success from major Agentic product launches, the analyst tells investors in a research note. While competitive challenges and new recurring revenue softness sustain, the overall execution on product and go-to-market fronts were solid, the firm added.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- Morning Movers: Trump says China ‘totally violated’ trade agreement
- UiPath price target raised to $15 from $12 at TD Cowen
- UiPath price target raised to $15 from $11 at Evercore ISI
- UiPath price target raised to $15 from $13 at RBC Capital
- UiPath: Balancing Optimism and Caution Amid Economic Uncertainty
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue